Global Over-the-Counter (OTC) Drug Markets Report 2018: Perrigo Is the Leading Off-Brand OTC Drug Company

DUBLIN, Feb. 19, 2018 /PRNewswire/ --

The "Global Over-the-Counter (OTC) Drug Markets" report has been added to ResearchAndMarkets.com's offering.

The global over-the-counter (OTC) drug market is highly fragmented by region. This is largely due to differences in economic conditions, perception of self-medication, education, access to medical advice and products, demographics, product availability, and incidence of diseases and medical conditions.

Global Over-the-Counter (OTC) Drug Markets discusses the global and regional OTC markets, including market data on the following:

• Global Over-the-Counter Drug Market Analysis: 2017 to 2023
• Top Twenty OTC Drug Markets, Country Market Share (%), 2017 (United States, Japan, China, Germany, France, India, Brazil, Russia, United Kingdom, Australia, Mexico, Canada, Italy, Spain, Poland, Turkey, Argentina, Venezuela, South Africa, Saudi Arabia, Rest of World)
• Total Pharmaceutical Markets: Prescription vs. Non-Prescription by Country, 2017 (% of total pharmaceutical market) (United States, Japan, China, Germany, France, India, Brazil, Russia, United Kingdom, Australia, Mexico, Canada, Italy, Spain, Poland, Turkey, Argentina, Venezuela, South Africa, Saudi Arabia)
• Global OTC Drug Market Analysis, Markets by Product Segment, 2017 to 2023 (Central Nervous System, Dermatological, Gastrointestinal, Respiratory, Other, Total)

Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription. By definition, the FDA has found them to be safe for use without medical supervision. As the pharmaceutical industry has grown, patients have become more involved in health-care issues and now have taken some medical treatment into their own hands. This has provided an opportunity for pharmaceutical companies to invest in research and development of OTC drugs. Drugs included in OTC segments are pain relievers, cough and cold remedies, sleeping aids, antifungals, and other products approved for use as a self-medication product.

This Study Divides and Discusses OTC Product Markets in Five General Segments:

• OTC Central Nervous System Agents (Analgesics, Anti-Inflammatories, and Other Central Nervous System Agents)
• OTC Dermatological Agents (Acne Treatments, Antifungals/Antiinfectives, Hair Growth Remedies, Others)
• OTC Gastrointestinal System Agents (Laxatives, Antacids, Antidiarrheals, H2 Antagonists, Proton Pump Inhibitors)
• OTC Respiratory System Agents (Antihistamines, Decongestants, Cough Preparations, Other Respiratory Agents)
• OTC Agents - Various Therapeutic Classifications (Smoking Cessation Market, Contraceptive Drugs, Weight Management Drugs [OTC drugs, not dietary supplements], Overactive Bladder Treatments)

The consumer healthcare market involves a range of large and small competitors. Although hundreds of companies compete in the world OTC drug market, a handful of companies secure leading positions. Many leading companies are taking advantage of new opportunities in developing regions, which is adding to the competitive landscape of the OTC market.

The report includes discussions of conditions often treated with OTC medicines, health statistics related to the industry, global populations, aging populations, populations by region and issues affecting the market as a whole.

Key Topics Covered:

1. Executive Summary

• Background
• Scope and Methodology
• Size and Growth of the Global OTC Market
• Global Markets
• Leading Competitors

2. Introduction

• Background
• Distribution and Safety Issues in the United States
• Consumer Advertising and Promotion
• Global Health
• Global Life Expectancy
• Global Trends in Birth Rates
• Tobacco Use
• Obesity
• Declining Growth of the Global Population
• Prescription vs. Over-the-Counter Industry
• Over-the-Counter Drug Product Segments
• Rx-to-OTC Switch Industry
• Economic Trends
• Purchasing Power Trends
• Health Insurance Issues and Trends: United States
• Consumer Issues and Trends
• Access to Professional Medical Services and the Link to Self-Medication
• Regulatory Solutions to OTC Drug Access
• Revisions to Pharmaceutical Affairs Law (PAL) in Japan
• Changes to Australia's OTC Drug Access - Up-scheduling Combination Medicines Containing Codeine

3. Over The Counter Central Nervous System Agents

• Market Summary
• Market By Drug Segment
• Markets by Region

4. Over-the-Counter Dermatological Agents

• Market Summary
• Market by Drug Segment
• Markets by Region

5. Over-the-Counter Gastrointestinal System Agents

• Market Summary
• Market by Drug Segment
• Markets by Region

6. Over-the-Counter Respiratory System Agents

• Market Summary
• Market by Drug Segment
• Markets by Region

7. Over-the-Counter Agents-Various Therapeutic Classifications

• Market Summary
• Markets by Region

8. OTC Drug Markets in Asia Pacific

• Regional Overview
• OTC Drug Sales and Growth in Asia Pacific Markets
• Sales for OTC Drug Markets by Country
• Asia Pacific OTC Markets by Therapeutic Class

9. OTC Drug Markets in Europe

• Regional Overview
• OTC Drug Sales and Growth in Europe Markets
• Sales for OTC Drug Markets by European Country
• Europe OTC Markets by Therapeutic Class

10. OTC Drug Markets in Latin America

• Regional Overview
• OTC Drug Sales and Growth in Latin America Markets
• Sales for OTC Drug Markets by Country
• Latin America OTC Markets by Therapeutic Class

11. OTC Drug Markets in Middle East & Africa

• Regional Overview
• OTC Drug Sales and Growth in Middle East & Africa Markets
• Sales for OTC Drug Markets by Country
• Middle East & Africa OTC Markets by Therapeutic Class

12. OTC Drug Markets in North America

• Regional Overview
• OTC Drug Sales and Growth in North America Markets
• North America OTC Markets by Therapeutic Class

13. Leading OTC Drug Manufacturers

• Overview
• Competitor Analysis
• GlaxoSmithKline Grabs Top Market Position
• Bayer Holds Second in a Highly Competitive Market
• Sanofi Climbs to Third in Market with Recent Acquisition
• Johnson & Johnson Maintains a Top Market Position in OTC Drugs despite Growing Consolidation and Competition
• Reckitt Benckiser Maintains Consistent Sales
• Perrigo Is the Leading Off-Brand OTC Drug Company
• Pfizer Is Steadfast
• Taisho Pharmaceutical: Japan's Leading OTC Drug Supplier
• Procter & Gamble Shows Slow, Steady Growth
• A Decade of Agreements, Mergers and Acquisitions Shaping the OTC Drug Market
• Sanofi and Boehringer Ingelheim
• GlaxoSmithKline and Novartis AG
• Bayer AG and Merck & Co.
• Prestige Brands and Insight Pharmaceuticals
• Perrigo Company Acquisitions
• Procter & Gamble and Teva Pharmaceutical Industries
• Sanofi and Chattem Consumer
• Wyeth and Pfizer
• Reckitt Benckiser and Adams Respiratory Therapeutics
• Leading Corporate Profiles
• Bayer AG
• GlaxoSmithKline plc
• Johnson & Johnson
• Mylan N.V.
• Perrigo Company plc
• Pfizer, Inc.
• Procter & Gamble Company
• Reckitt Benckiser Group Plc
• Sanofi
• Taisho Pharmaceutical Holding Co., Ltd.

14. List of Tables

For more information about this report visit https://www.researchandmarkets.com/research/wxk5jz/global?w=5

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets